Technical Analysis for BIO - Bio-Rad Laboratories, Inc.

Grade Last Price % Change $ Change
grade B $192.06 -0.63% -1.21
BIO closed down 0.63 percent on Tuesday, February 21, 2017, on approximately normal volume. The bulls were able to push the stock to a new 52-week high. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Feb 23

Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical BIO trend table...

Date Alert Name Type % Chg
Feb 21 New 52 Week High Bullish 0.00%
Feb 21 Stochastic Sell Signal Bearish 0.00%
Feb 15 Stochastic Reached Overbought Other -0.08%
Feb 8 Hammer Candlestick Bullish 1.46%
Feb 3 Bollinger Band Squeeze Range Contraction 0.50%
Feb 2 NR7 Range Contraction 1.45%
Feb 2 Narrow Range Bar Range Contraction 1.45%
Feb 2 Bollinger Band Squeeze Range Contraction 1.45%
Feb 1 Bollinger Band Squeeze Range Contraction 1.28%
Jan 31 Bollinger Band Squeeze Range Contraction 1.04%

Older signals for BIO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.

Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, and to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network worldwide. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Is BIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 194.25
52 Week Low 130.12
Average Volume 161,717
200-Day Moving Average 162.45
50-Day Moving Average 186.24
20-Day Moving Average 189.77
10-Day Moving Average 191.05
Average True Range 2.86
ADX 23.86
+DI 20.38
-DI: 12.52
Chandelier Exit (Long, 3 ATRs) 185.67
Chandelier Exit (Short, 3 ATRs) 192.01
Upper Bollinger Band 194.03
Lower Bollinger Band 185.51
Percent B (%b) 0.77
Bandwidth 0.044896